Deal title |
Principal company |
Partner company |
Total paid (US$M) |
Technologies |
Date |
June | |||||
Johnson & Johnson acquires Actelion |
Actelion Ltd. |
Johnson & Johnson |
$30,000 |
Small-molecule therapeutic (primary); Film coating; Oral formulation; Tablet formulation |
6/16/17 |
UCB Pharma acquires Beryllium Discovery |
Beryllium Discovery Corp. |
UCB Pharma Ltd. |
Unknown |
Other technologies (primary); Service laboratory deal |
6/6/17 |
Cell Medica acquires Catapult Therapy TCR |
Catapult Therapy TCR Ltd. |
Cell Medica Ltd. |
Unknown |
Cell therapy (primary) |
6/20/17 |
Intrexon acquires Genvec |
Genvec Inc. |
Intrexon Corp. |
Unknown |
N/A |
6/16/17 |
Spherix acquires a controlling interest in Hoth Therapeutics |
Hoth Therapeutics Inc. |
Spherix Inc. |
Unknown |
Small-molecule therapeutic (primary) |
6/30/17 |
Eco Petroleum acquires Immunotech Laboratories |
Immunotech Laboratories Inc. |
Eco Petroleum Solutions |
Payment unspecified |
Protein technology |
6/14/17 |
Corazon Gold acquires Nanosphere Health |
Nanosphere Health Sciences LLC |
Corazon Gold Corp. |
$20 |
Nanoparticle formulation (primary) |
6/20/17 |
Bioverativ acquires True North Therapeutics |
True North Therapeutics |
Bioverativ Inc. |
$400 |
Monoclonal antibody (primary); Biological therapeutic; Immunoglobulin-G; Intravenous formulation; Monoclonal antibody humanized |
6/28/17 |
July | |||||
Dare Bioscience reverse merges with Cerulean Pharma |
Cerulean Pharma |
Dare Bioscience Operations Inc. |
Unknown |
Small-molecule therapeutic (primary) |
7/19/17 |
Lentigen Technology acquires UMB's Living Pharma |
Living Pharma Inc. |
Opus Bio Inc. |
Unknown |
Cell therapy (primary); T-lymphocyte |
7/20/17 |
Norgine acquires Merus Labs |
Merus Labs International Inc. |
Norgine BV |
Payment unspecified |
Other technologies |
7/17/17 |
Alpine merges with Nivalis Therapeutics in an all-stock transaction |
Nivalis Therapeutics |
Alpine Immune Sciences Inc. |
Unknown |
Small-molecule therapeutic (primary) |
7/24/17 |
August | |||||
Carlyle Group acquires Albany Molecular Research Inc. |
Albany Molecular Research Inc. |
The Carlyle Group |
Payment unspecified |
Other technologies (primary); Service laboratory deal |
8/31/17 |
Arrow Pharmaceuticals acquires Amneal Pharmaceuticals |
Amneal Pharmaceutical LLC |
Arrow Pharmaceuticals Ltd. |
$13.5 |
Generic product (primary); OTC product |
8/31/17 |
Evotec acquires Aptuit |
Aptuit |
Evotec AG |
$300 |
Other technologies |
8/16/17 |
Charles River Laboratories acquires Brains On-Line |
Brains On-Line Holding BV |
Charles River Laboratories International Inc. |
$21.23 |
Other technologies (primary); Service laboratory deal |
8/7/17 |
Tissue Regenix acquires Cellright Technologies |
Cellright Technologies |
Tissue Regenix Group plc |
$25.9 |
Other technologies |
8/9/17 |
Aclaris Therapeutics acquires Confluence Life Sciences |
Confluence Life Sciences Inc. |
Aclaris Therapeutics Inc. |
$19.69 |
Small-molecule therapeutic (primary); Oral formulation |
8/3/17 |
Horizon Discovery acquires GE Healthcare Dharmacon |
Dharmacon Inc. |
Horizon Discovery Group plc |
Unknown |
Genomics (primary); Lab reagents and supplies deal |
8/31/17 |
Mirna Therapeutics reverse merges with Synlogic |
Mirna Therapeutics Inc. |
Synlogic Inc. |
Unknown |
Small-molecule therapeutic (primary) |
8/28/17 |
Oncogenex Pharmaceuticals reverse merges with Achieve Life Science |
Oncogenex Pharmaceuticals |
Achieve Life Science Inc. |
Unknown |
Oligonucleotide (primary) |
8/1/17 |
Thermo Fisher Scientific acquires Patheon |
Patheon Inc. |
Thermo Fisher Scientific Inc. |
$7,200 |
Other technologies (primary); Service laboratory deal |
8/29/17 |
Molecular Templates reverse merges with Threshold Pharmaceuticals to form a combined company |
Threshold Pharmaceuticals Inc. |
Molecular Templates Inc. |
Unknown |
Small-molecule therapeutic (primary) |
8/1/17 |
Immunoprecise acquires U-Protein |
U-Protein Express BV |
Immunoprecise Antibodies Ltd. |
Unknown |
Antibody (primary); Protein recombinant |
8/23/17 |
Parcom Capital acquires Viroclinics Biosciences |
Viroclinics Biosciences |
Parcom Capital Management BV |
Unknown |
Other technologies |
8/29/17 |
CGI acquires Vivopharm |
Vivopharm Pty. Ltd. |
Cancer Genetics Inc. |
$12 |
Other technologies |
8/14/17 |
September | |||||
GT Biopharma acquires Georgetown Translational Pharmaceuticals |
Georgetown Translational Pharmaceuticals Inc. |
GT Biopharma Inc. |
Unknown |
Small-molecule therapeutic (primary) |
9/1/17 |
BMS acquires IFM Therapeutics |
IFM Therapeutics Inc. |
Bristol-Myers Squibb Co. |
$300 |
Small-molecule therapeutic (primary) |
9/7/17 |
Mallinckrodt acquires Infacare |
Infacare Pharmaceutical Corp. |
Mallinckrodt plc |
$425 |
Small-molecule therapeutic (primary) |
9/25/17 |
Metabolon acquires Metabolomic Discoveries |
Metabolomic Discoveries GmbH |
Metabolon Inc. |
Unknown |
Other technologies |
9/5/17 |
Northeast Pharmaceutical Group acquires Nanjing Real |
Nanjing Real Pharmaceutical Co. Ltd. |
Northeast Pharmaceutical Group Co. Ltd. |
$18.29 |
Small-molecule therapeutic (primary) |
9/4/17 |
Acer Therapeutics reverse merges with Opexa Therapeutics |
Opexa Therapeutics |
Acer Therapeutics Inc. |
Unknown |
Cell therapy (primary) |
9/20/17 |
|
Notes Source: Cortellis Deals Intelligence |